Scottsdale, Arizona 8/21/2009 12:14:32 AM
News / Finance

Vicor Technologies, Inc. (VCRT.OB) Announces International Distribution Agreement; Revenues Expected to Commence in the Fourth Quarter of 2009

QualityStocks would like to highlight Vicor Technologies, Inc. (OTCBB: VCRT). Vicor Technologies is a development-stage biotechnology company creating innovative non-invasive diagnostics employing its patented, proprietary point correlation dimension algorithm (PD2i). The PD2i is a deterministic, non-linear measure that analyzes electrophysiological potentials to predict future pathological events with a high degree of accuracy in target populations.

 

In the company’s news yesterday,

 

Vicor Technologies, Inc. announced that the company has entered into an exclusive distributorship agreement with Glotecx, Inc. for the distribution of its PD2i Cardiac Analyzer. This agreement grants Glotecx, Inc., a global provider of state-of-the-art medical equipment, the exclusive right to purchase, inventory, promote and resell the private label Vicor PD2i Cardiac Analyzer, and accompanying computer hardware and test analyses in India, Kenya, Uganda, Tanzania and Nigeria.

 

Vicor Technologies’ patented and proprietary PD2i algorithm and software assists patients at risk of sudden cardiac death (SCD) and trauma victims in need of life saving intervention. According to the terms of the agreement that will commence on October 1, 2009, Glotecx guarantees to pre-pay Vicor for a pre-determined minimum amount of equipment and test analyses, with payment for equipment and test analyses in excess of the minimum guaranteed amount payable monthly.

 

David H. Fater, chief executive officer of Vicor Technologies, stated, “We are pleased to have entered into this international distribution agreement with Glotecx. Glotecx is a leading provider of cutting-edge medical equipment to nations worldwide and is extremely well positioned in the countries covered by this agreement.” Mr. Fater continued, “Consequently, we are confident that our PD2i Cardiac Analyzer will be well-represented and distributed widely in the countries covered by this agreement. Most importantly, with pre-payment for a minimum amount of equipment and test analyses guaranteed, Vicor should achieve another milestone — commencement of revenue generation — during the fourth quarter of 2009.”

 

About QualityStocks

 

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.

 

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net 

 

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.